Welcome to the Daily Picks! Where Uptick staff looks for new companies to feature, giving readers the opportunity to find new possibilities for their investment portfolios.
DKGR: Universal Apparel & Textile Company
Universal Apparel & Textile Company (DKGR:OTC) is pleased to announce that it has received a trial order for ladies, two pocket, long sleeve shirts through its joint venture with BD Impotex LLC from a preferred vendor of Burlington Stores Inc. (BURL:NYSE). The product is to be made out of 100% viscose with polka dot and stripes prints. BD Impotex has developed the specific viscose to be used at the request of the vendor in conjunction with Burlington Stores Inc.. The product will be sold only at Burlington Coat Factory stores.
Mr. Kabir, CEO of Universal Apparel and Textile Company states, “We are very excited about receiving this purchase order. These type of projects were envisioned when we entered into a joint venture with BD Impotex. BD Impotex has long been serving chain stores like Burlington Stores Inc (BURL:NYSE) directly and through preferred vendors This is only a trial order for us but once successfully delivered to Burlington Stores Inc., it is expected to lead to additional orders with quarterly volume of approximately 30,000 units with a wholesale value of about $250,000.”
OMCM: OmniComm Systems, Inc.
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that one of the top 5 medical research universities in the US, selected OmniComm TrialMaster® EDC and related services to conduct a series of clinical studies over a five year period.
OmniComm TrialMaster EDC was selected from a broad field of competitors for its inherent flexibility, scalability, data quality, and broad capabilities. Realizing the benefits of eSource is an important initiative for this academic research center. OmniComm’s expertise and know-how integrating electronic medical record (EMR) systems with TrialMaster EDC was an important factor in the decision. TrialMaster EDC will integrate with their EMR system, enabling a comprehensive eSource solution. Data captured from the EMR will be automatically imported into the clinical study in TrialMaster, speeding the process of data capture and reducing errors. OmniComm will use the Retrieve Form for Data-capture (RFD) integration profile that was co-developed by CDISC and Integrating the Healthcare Enterprise (IHE), a healthcare interoperability enabler.
Uptick encourages investors to do their own due diligence in determining investment strategies that work for them. Uptick’s opinion is based upon individual company and market factors. Invest at your own risk.